checkAd
    Startseite > Aktien > Adamis Pharmaceuticals > Nachrichten
    Adamis Pharmaceuticals
    Aktie
    ISIN: US00547W2089 WKN: A1XA2F SYM: ADMP Land USA
    0,0500
     
    USD
    0,00 %
    0,0000 USD
    Letzter Kurs 20.05.23 Nasdaq
    Geldkurs
    19.05.23
    0,0501
     
    USD
    10.600 STK
    Briefkurs
    19.05.23
    0,0519
     
    USD
    21.300 STK

    Adamis Pharmaceuticals Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI
    21.12.23 · globenewswire · Adamis Pharmaceuticals
    DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI and Provides Corporate Update
    28.11.23 · globenewswire · Adamis Pharmaceuticals
    DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
    14.11.23 · globenewswire · Adamis Pharmaceuticals
    DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023
    13.11.23 · globenewswire · Adamis Pharmaceuticals
    DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)
    30.10.23 · globenewswire · Adamis Pharmaceuticals
    DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)
    20.10.23 · globenewswire · Adamis Pharmaceuticals
    DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of Growth
    19.10.23 · globenewswire · Adamis Pharmaceuticals
    Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus
    07.09.23 · globenewswire · Adamis Pharmaceuticals
    Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
    21.08.23 · globenewswire · Adamis Pharmaceuticals
    Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering
    04.08.23 · globenewswire · Adamis Pharmaceuticals
    Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
    02.08.23 · globenewswire · Adamis Pharmaceuticals
    Adamis Pharmaceuticals to Fund ZIMHI Clinical Study with University of Leiden Opioid Expert
    28.07.23 · globenewswire · Adamis Pharmaceuticals